Abatacept for Treating Rheumatoid Arthritis After the Failure of Conventional Disease-Modifying Anti-Rheumatic Drugs (TA280)

Tocilizumab for the Treatment of Rheumatoid Arthritis (TA247)

Golimumab for the Treatment of Ankylosing Spondylitis (TA233)

Golimumab for the Treatment of Rheumatoid Arthritis After the Failure of Previous Disease-Modifying Anti-Rheumatic Drugs (TA225)

Golimumab for the Treatment of Psoriatic Arthritis (TA220)

Adalimumab, Etanercept, Infliximab, Rituximab and Abatacept for the Treatment of Rheumatoid Arthritis after the Failure of a TNF Inhibitor (TA195)

Etanercept, Infliximab and Adalimumab for the Treatment of Psoriatic Arthritis (TA199)

Certolizumab Pegol for the Treatment of Rheumatoid Arthritis (TA186)

Ankylosing Spondylitis: Adalimumab, Etanercept, Infliximab (NICE)

Rheumatoid Arthritis: Adalimumab, Etanercept, Infliximab (NICE)

Load More